BCP-ALL patients with the recurrent translocations ETV6::RUNX1, BCR::ABL1, and TCF3::PBX1 carried few driver mutations compared to other BCP-ALL patients. This evidence concerns the gene TCF3 and acute lymphoblastic leukemia.